Buyer profile
GWQ ServicePlus AG
Every award we hold where this buyer named a supplier, in DEA11, Germany, from 8 Nov 2010 to 30 Sept 2026— with what is open now and what ends soon.
Awards
210
naming a supplier
Attributed value
€61
78 shared, unvalued
Suppliers
649
awarded to
Active
2010–2026
first to latest award
Open right now
Notices from this buyer still open for bids, soonest deadline first. Each links to the buyer's own notice; deadlines are as published.
Contracts ending soon
Awards whose notice published a contract end date in the next eighteen months, among awards published in the last 5 years. A notice without an end date is not listed — nothing is inferred.
- Germany – Pharmaceutical products – 31. Generikaausschreibung (2;3er) Auftragsvergabe ↗ends 31 Dec 2026ratiopharm GmbH, Hexal AG, Zentiva Pharma GmbH, BG Heumann / Heunet GbR, HEC Pharm GmbH, Exeltis Germany GmbH, Pfizer Pharma GmbH, Aristo Pharma GmbH, neuraxpharm Arzneimittel GmbH, Accord Healthcare GmbH, BG ALIUD / STADAPHARM GbR, Dexcel Pharma GmbH, Cipla Europe NV, Devatis GmbH, Micro Labs GmbH, Glenmark Arzneimittel GmbH, PUREN Pharma GmbH & Co. KG, TAD Pharma GmbH, Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH, Gedeon Richter GmbH, Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg, axunio Pharma GmbH, Denk Pharma, Hormosan Pharma GmbH, mibe GmbH Arzneimittel, Amarox Pharma GmbH, betapharm Arzneimittel GmbH, Basics GmbH, Ascend GmbH, Bluefish Pharma GmbH, G.L. Pharma Deutschland GmbH, EVER Pharma GmbH, HIKMA PHARMA GMBH, ribosepharm division, Medical Valley Invest AB, Abdi Farma GmbH, Libra-Pharm GmbH, medac GmbHawarded 9 Jul 2024ted-eu
- Germany – Pharmaceutical products – BvA_Patent_80.3 ↗ends 31 Dec 2026
- Germany – Pharmaceutical products – 31. Generikaausschreibung (Antibiotika) - Auftragsvergabe ↗ends 31 Dec 2026Hexal AG, AAA-Pharma GmbH, PUREN Pharma GmbH & Co. KG, Micro Labs GmbH, Abanta Pharma GmbH, Aristo Pharma GmbH, TAD Pharma GmbH, Ascend GmbH, Zentiva Pharma GmbH, HIKMA PHARMA GMBH, ribosepharm division, BG Heumann / Heunet GbR, Viatris Healthcare GmbH, Zweigniederlassung Bad Homburgawarded 9 Jul 2024ted-eu
- Germany – Pharmaceutical products – BvA_Patent_80.1 ↗ends 31 Dec 2026
- Germany – Pharmaceutical products – BvA_Patent_80.2 ↗ends 31 Dec 2026
- Germany – Pharmaceutical products – 31. Generikaausschreibung (1a) Auftragsvergabe ↗ends 31 Dec 2026ETHYPHARM GmbH, BG ALIUD / STADAPHARM GbR, PUREN Pharma GmbH & Co. KG, Theramex Germany GmbH, BG TEVA ratiopharm GbR, Micro Labs GmbH, neuraxpharm Arzneimittel GmbH, Dermapharm AG, DESMA GmbH, Hexal AG, Denk Pharma GmbH & Co. KG, Aristo Pharma GmbH, DR KADE Pharmazeutische Fabrik GmbH, ROVI GmbH, BG Heumann / Heunet GbR, Zentiva Pharma GmbH, Cipla Europe NV, Almirall Hermal, Hikma Pharma GmbH, Gedeon Richter GmbH, medac GmbH, Advanz Pharma Germany GmbH, Viatris Healthcare GmbH, Zweigniederlassung Bad Homburgawarded 9 Jul 2024ted-eu
Awards by year
Who they award to
| Supplier | Awards | Value |
|---|---|---|
| Hexal AG | 42 | not attributable |
| Aristo Pharma GmbH | 41 | not attributable |
| BG ALIUD / STADAPHARM GbR | 36 | not attributable |
| neuraxpharm Arzneimittel GmbH | 36 | €2 |
| Micro Labs GmbH | 34 | not attributable |
| PUREN Pharma GmbH & Co. KG | 32 | not attributable |
| TAD Pharma GmbH | 32 | not attributable |
| BG Heumann / Heunet GbR | 31 | not attributable |
| Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg | 31 | not attributable |
| ratiopharm GmbH | 27 | not attributable |
What they buy
Selling to them?
Get this buyer's new notices in a daily digest, scored against your own capability — plus the full record behind each award, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. The buyer's published spellings are grouped by case, punctuation and spacing only; nothing that could mark a different body is removed, so a council and its housing department, or a trust and its charity, stay separate. An award counts here only where its notice named at least one supplier. Value is attributed only where the notice is explicit: a supplier's own itemised amount, or the whole value where one supplier was named. Awards naming several suppliers without a published split are counted and marked shared, never valued; a framework ceiling is never treated as money a supplier won; nothing is estimated. Every currency is reported separately, never summed. Contract end dates are the ones the notice published, looked for among awards published in the last 5 years. The linked source notice is authoritative.